Clinical Roundup Antibody-drug conjugate achieves high response rates as frontline treatment in aggressive, rare blood cancer February 20, 2026Vol.52 No.07
Clinical Roundup Mount Sinai study strengthens evidence supporting lung-sparing surgery in mesothelioma February 20, 2026Vol.52 No.07
Clinical Roundup Lung cancer drug offers a surprising new treatment against ovarian cancer, Mayo study finds February 20, 2026Vol.52 No.07
Clinical Roundup Different KRAS mutations affect how tumors interact with the immune system, UTSW-led study finds February 20, 2026Vol.52 No.07
Clinical Roundup Exposure to pathogenic bacteria significantly increased SMOX activity, leading growth and metastasis of breast cancer, JHU-led study finds February 20, 2026Vol.52 No.07
Clinical Roundup Advanced PET/CT imaging can improve long-term outcomes in recurrent prostate cancer, UCLA-led study finds February 13, 2026Vol.52 No.06
Clinical Roundup Rural cancer patients do just as well as urban patients when having surgery close to home, study finds February 13, 2026Vol.52 No.06
Clinical Roundup AI tool may help personalize ovarian cancer treatment from day one February 13, 2026Vol.52 No.06
Clinical Roundup HPV cancer vaccine slows tumor growth, extends survival in animal models February 13, 2026Vol.52 No.06
Clinical Roundup Immunity against CMV leveraged against pancreatic cancer in study by UCSD, La Jolla Institute of Immunology February 13, 2026Vol.52 No.06
